|
Male |
Female |
|
Class 1 A |
−0.23 |
0.03 |
Likely will not reach ESRD; reassure patient |
Class 1 B |
−1.33 |
−1.13 |
Slowly progressing disease; monitor patient |
Class 1 C |
−2.63 |
−2.43 |
Rapidly progressing disease; propose treatment |
Class 1 D |
−3.48 |
−3.29 |
Rapidly progressing disease; propose treatment |
Class 1 E |
−4.78 |
−4.58 |
Rapidly progressing disease; propose treatment |
Class 2: Atypical |
|
Class 2 A: |
Unilateral |
Diffuse cystic involvement of one kidney causing marked kidney enlargement with a normal contralateral kidney defined by a normal kidney volume (<275 ml in men; <244 ml in women) and having no or only 1–2 cysts |
|
Segmental |
Cystic disease involving only one pole of one or both kidneys and sparing the remaining kidney tissue |
|
Asymmetric |
Diffuse cystic involvement of one kidney causing marked kidney enlargement with mild segmental or minimal diffuse involvement of the contralateral kidney defined by a small number of cysts (>2 but <10) and volume accounting for <30% of TKV |
|
Lopsided |
Bilateral distribution of kidneycysts with mild replacement of kidney tissue with atypical cysts where ≤5 cysts account for ≥50% TKV (the largest cyst diameter is used to estimate individual cyst volume) |
Class 2 B: |
Bilateral presentation with acquired unilateral atrophy |
Diffuse cystic involvement of one kidney causing moderate to severe kidney enlargement with contralateral acquired atrophy. |
|
Bilateral presentation with bilateral kidney atrophy |
Impaired kidney function (serum creatinine≥1.5 mg/dl) without significant enlargement of the kidneys, defined by an average length <14.5 cm, and replacement of kidney tissue by cysts with atrophy of the parenchyma. |